Replies to post #113 on Merck and Co Inc (MRK)

[DewDiligence]

Don’t get too giddy—Singulair, MRK’s largest-selling drug by far, goes off-patent in the US next week:

http://www.accessdata.fda.gov/scripts/cder/ob/docs/patexclnew.cfm?Appl_No=021409&Product_No=001&table1=OB_Rx

[johnsyn]

pre-market up $1.05